|
|
Volumn 240, Issue 6, 2002, Pages 430-435
|
|
Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
EYE DROPS;
TIMOLOL;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTERIAL PRESSURE;
ARTICLE;
BINDING ASSAY;
CARDIOPULMONARY HEMODYNAMICS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR EFFECT;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG ADMINISTRATION ROUTE;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG EFFECT;
DRUG ELIMINATION;
DRUG HALF LIFE;
FEMALE;
FORCED EXPIRATORY VOLUME;
HEART RATE;
HUMAN;
HUMAN EXPERIMENT;
INTRAOCULAR PRESSURE;
LUNG DISEASE;
LUNG FUNCTION;
MALE;
NORMAL HUMAN;
PHARMACOLOGICAL PARAMETERS;
PRIORITY JOURNAL;
SIDE EFFECT;
VOLUNTEER;
ABSORPTION;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
AREA UNDER CURVE;
BIOLOGICAL AVAILABILITY;
BLOOD PRESSURE;
CROSS-OVER STUDIES;
EYE;
FEMALE;
FORCED EXPIRATORY VOLUME;
HEART RATE;
HUMANS;
INTRAOCULAR PRESSURE;
MALE;
OPHTHALMIC SOLUTIONS;
TIMOLOL;
VITAL CAPACITY;
|
|
EID: 0036956566
PISSN: 0721832X
EISSN: None
Source Type: Journal
DOI: 10.1007/s00417-002-0462-2 Document Type: Article |
|
Times cited : (120)
|
|
References (14)
|
